In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Is Spine Surgery Under Assault?

Executive Summary

A recent article published in JAMA has spine surgeons crying foul. The article contends that spending on spine care increased 65% between 1997 and 2005--no big surprise given that healthc are spending in general increased by a similar amount over the same period. But an aggressive PR campaign behind the article seemed to single out surgery as a prime culprit in the rising costs and carried a clear message: that we're spending a lot on spine surgery and getting little in return. Moreover, claim surgeons, the article is just the latest in what they see as a larger campaing to cast doubts on the value of spine surgery and deny care to patients.
Advertisement

Related Content

SPOC Inc. (Stevens Proof of Concept)
Clinical Edge
Clinical Edge
Spine Market: Are the Good Times Over?
Ortho Dx: Where Does It Hurt?
OrthoMEMS: Measuring What Matters in Spine

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV003119

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel